Mehta Vimal 4
4 · BioXcel Therapeutics, Inc. · Filed Jan 10, 2025
Insider Transaction Report
Form 4
Mehta Vimal
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2025-01-07+660,000→ 660,000 totalExercise: $0.47Exp: 2035-01-07→ Common Stock (660,000 underlying)
Footnotes (1)
- [F1]On January 7, 2025, the Reporting Person was granted an option to purchase 660,000 shares of common stock, which vests in twelve equal monthly installments over a twelve-month period following the grant date, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.